Evidence of astrogliosis in rat hippocampus after d-amphetamine exposure

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Sep 30;30(7):1231-4. doi: 10.1016/j.pnpbp.2006.03.016. Epub 2006 Apr 21.

Abstract

Introduction: Psychostimulants such as amphetamine (AMPH) induce manic-like symptoms in humans and studies have suggested that bipolar disorder (BD) may be associated to dopamine dysfunction. Glial fibrillary acidic protein (GFAP) up-regulation is considered a marker of astrogliosis, and it has been associated to behavioral sensitization.

Purpose: We aimed to investigate the behavioral effects of acute and chronic AMPH on rat locomotion and assess GFAP levels in rat cortex and hippocampus.

Methods: Rats were administered either acute (single dose) or chronic (seven days) d-amphetamine IP injection. Locomotion was assessed with an open-field test and GFAP immunoquantity was measured using ELISA.

Results: Chronic, but not acute, administration of AMPH increased GFAP levels in rat hippocampus. No differences were observed in rat cortex.

Conclusions: Repeated exposure to AMPH leads to an astroglial response in the hippocampus of rats.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analysis of Variance
  • Animals
  • Astrocytes / drug effects*
  • Behavior, Animal / drug effects
  • Central Nervous System Stimulants / administration & dosage*
  • Cerebral Cortex / drug effects
  • Cerebral Cortex / metabolism
  • Dextroamphetamine / administration & dosage*
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Enzyme-Linked Immunosorbent Assay / methods
  • Gene Expression / drug effects
  • Glial Fibrillary Acidic Protein / drug effects
  • Hippocampus / cytology*
  • Hippocampus / drug effects*
  • Hippocampus / metabolism
  • Immunohistochemistry / methods
  • Male
  • Motor Activity / drug effects
  • Rats
  • Rats, Wistar

Substances

  • Central Nervous System Stimulants
  • Glial Fibrillary Acidic Protein
  • Dextroamphetamine